SCHEMBL4481685

SCHEMBL4481685

CCOC(=O)c1sc(-c2ccc3c(c2)CCO3)nc1Nc1ccccc1Cl

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.55
RAB9A P51151 3/20 0.55
CLK1 P49759 2/20 0.55
CHEK1 O14757 3/20 0.49
MAPT P10636 4/20 0.48
CASP3 P42574 1/20 0.48
SENP8 Q96LD8 1/20 0.48
SENP7 Q9BQF6 1/20 0.48
SENP6 Q9GZR1 1/20 0.48
FABP3 P05413 4/20 0.46
FABP4 P15090 4/20 0.46
FABP5 Q01469 2/20 0.46
KMT2A Q03164 2/20 0.44
MEN1 O00255 1/20 0.44
LMNA P02545 1/20 0.44
MAPK1 P28482 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
TRPM8 Q7Z2W7 3/20 0.44
CDC7 O00311 3/20 0.43
DBF4 Q9UBU7 3/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4489488 0.86 FABP4 (0.51) NPC1RAB9ACLK1CHEK1FABP3
SCHEMBL3828856 0.86 FABP4 (0.56) CHEK1FABP3FABP4FABP5KDM4E
SCHEMBL13675570 0.78 FABP4 (0.47) CHEK1FABP3FABP4FABP5KDM4E
SCHEMBL3825249 0.75 PLA2G10 (0.43) NPC1RAB9ACLK1CHEK1MAPT
SCHEMBL13674672 0.75 PLA2G10 (0.48) NPC1RAB9ACLK1CHEK1MAPT
SCHEMBL4499933 0.73 CLK1 (0.56) NPC1RAB9ACLK1CHEK1MAPT
SCHEMBL1328083 0.70 PLA2G10 (0.60) NPC1RAB9ACLK1CHEK1MAPT
SCHEMBL2885197 0.69 NPC1 (0.58) NPC1RAB9ACLK1CHEK1MAPT
SCHEMBL16365894 0.68 NPC1 (0.82) NPC1RAB9ACLK1CHEK1KMT2A
SCHEMBL10288174 0.68 CDC7 (0.67) SMN1; SMN2TRPM8CDC7DBF4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090270456-A1 Novel chemical compounds HASEGAWA MASAICHI 2009-10-29 US disclosed
US-20090270456-A1 Novel chemical compounds HASEGAWA MASAICHI 2009-10-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090270456-A1 Novel chemical compounds HIPK3, HIPK2, HIPK1 NPC1 3796/4885RAB9A 2187/4885CLK1 247/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.